Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

discontinuation * DMP 51

-Keyword

Abstract

Keyword

Abstract

) and phase angle after of human growth hormon 32182
cal survey/Reasons for of protease inhibitor treat 32353
n/Low rate of nelfinavir in a clinic population/Lo 60273
viremia despite antiviral for 14 months/Long-term 61000
ts treated with HAART/ Discontinue primary prophylaxis regimen 31225
xoplasmosis be safely discontinued in HIV-infected patients suc 12268
rescribed or why is it -A prospective analysis in t 446*/32335
w relationships and HIV discordance rates among couples reques 23149
ubtype B from non-B/ Discordances between peptide serotypin 11193
sion, a case of Uganda/ Discordant couples! A silent high risk grou 23165
d through a case study/ heterosexual couples (female 32425
cuss those differences/ partnerships: Production of vid 33467
ital stability among HIV discordant couples in northern Thailand/ 14169
partners/HIV+ MSM in relationships report sexual risk 14176
ne reconstitution of HIV monozygotic twins: Insight into 272*/22411
Kampala, Uganda/HIV and high risk HIV negative cou 23166
at the HIV infection in a couple: A study conducted in L 22200
ety to AIDS challenge/ Discourse analysis of the development of 60022
o drugs fail people: The discourse of "adherence"/Do people fail d 638*/34212
ent HIV/STD infection/ Discovering what schools in China are doi 13517
A collaboration across discplines /Developing family-centred car 24203
consent for HIV testing: Discrepancies between policy on the boo 44111
e combination therapy/ Discrepant immunologic and virologic res 342*/32259
cs/Relentless rises and discrete declines of the world HIV epidemi 13102
ensitive parameter to discriminate between HIV1-positive and 42110
m. Working to reduce it/ Discrimination: A drug related harm. Wor 33416
ouble reactive samples/ between HIV-1 and HIV-2 41160
eople and HIV/AIDS:,jurisdictional divisions, te 44167
tion, PLWHA response/ and stigmatization, PLWH 44168
in relation to HIV/AIDS/ and stigmatisation in relati 60136
Challenging stigma and discrimination: Promoting a positive atmo 13432
IV infection and related: Findings from three intern 13510
chool: Information vs. /Primary school: Informati 13556
vernment answer to the in HIV/AIDS in Brazil/Net 44138
Switzerland/HIV/AIDS in an industrialised country 44170
workplace/Combating faced by HIV infected at th 44178
y of defense because of in the military force/Suit ag 44182
-AIDS, in Chile/Laboral to persons living with HIV- 60751
olivia: Transform the discriminatory actors in potential subjects 44180
f video which leads to discuss those differences/Discordant part 33467
y testing clinic (SDTC) their need for an HIV test with thei 43144
ans in New York State/ Discussion of the process and activities a 42225
eliefs; barriers to sex discussion among married couples and it 205*/14213
xposure to AIDS and with friends or family in Bomba 33446
DS through focus group for factory workers/Behavior c 33544
Formation of a tripartite group comprised of the Chilea 60760
hips, sexuality and STD discussions in a sport club/"Me and my te 13581
on/Parent-adolescent about sexual initiation: Redu 14138
anda/Promoting open about sexuality to enable beh 14316
search opportunities for disenfranchised populations/Providing a 42358
+ women/Acute stress disorder assessment and intervention in n 24239
ociated neurocognitive /Change in CSF RNA level correl 32198
study of gender identity and HIV disease/Case control st 60177
s/Antisocial personality and HIV behavior risk in drug use 60278
podystrophy metabolic disorders due to protease inhibitor contain 12299
ological and psychiatric in HIV-positive individuals -The 12449
V infection/Psychiatric in patients with HIV infection/Ps 24221
G charting data in CNS evaluation in patients with HIV i 32226
ed children/Cutaneous in HIV-infected children/Cutane 32273
-1 proteins among HLA disparate North Americans and Thais/Cro 602*/31128
growing a life that is not dispensable: The perspective of five HIV+ 34131
DS in Brazil/Preventing displacement of children orphaned by AID 421*/24220
lizes HIV-1 infection by displacing envelope gp120 from the virion 21143
ifabutin absorption and disposition in HIV-infected patients with o 32171
DS as signal-mediated disruption of T-cell homeostasis: Activatio 21117
Consortium/Sources of dissatisfaction with health care among HI 12442
tudy in the HAART era/ Disseminated Mycobacterium avium com 22168
mosis in AIDS patients/ histoplasmosis in AIDS pati 22224
decision analytic view/ Mycobacterium avium com 43481
ment in an AIDS patient/ Kaposi's sarcoma with pleu 60914
DS patients treated for disseminated tuberculosis: Role of cortico 22130
rom AIDS patients with MAC disease/Clinical corre 22169
rsons with and without MAC and highly active antir 22171
atient with AIDS/Acute histoplasmosis and Pneum 22228
blood cultures to detect BCG among hospitalized c 60311

Mycobacterium causing infections in Brazil/Prelimin 60412
groups in Bangladesh/ Disseminating knowledge on AIDS preve 33348
Worldwide-Web site for disseminating information about evaluati 44305
alternative therapy" for AIDS knowledge to memb 60214
ogram and information for hemophilics living with 13397

n in Buenos Aires/HIV among several subgroups 14319
galovirus (CMV) blood in HIV-infected patients (Pr 22248
e PCP/Extrapulmonary of Pneumocystis carinii in i 31220
r worldwide information /Monitoring the AIDS pand 33444
re for AIDS information on the net: Two years later 34317
/Treatment information and decision-making amo 42237
strategic plan for the and implementation of the 42411
tive/Development and of an HIV/AIDS policy resp 44271
roup/Colonisation and of HIV-related Mycobacteri 60170
ation therapy through a dissociated viremia-CD4 T-cell response 341*/12101
HIV gag region that are distal from deletion mutations in the dimeri 378*/11126
g use prevention/Long distance training of elementary and first gr 13514
awareness among long truck drivers in India/Risk behavi 24115
on project among long drivers (LDD) in Cross River Stat 33373
ale sex partners of long drivers (LDDs) on HIV/AIDS/STD 43176
orld health organisation learning material on safe blood a 60485
geographic and cultural distances /HIV education in native North A 13410
hic characteristics that distinguish participants in HIV/AIDS prev 24186
measurement: How to primo-infected from old infect 41110
nd anti-HIV-2 assays to between HIV-1 and HIV-2 infe 42121
and HMA genotyping in distinguishing HIV-1 subtype B from non- 11193
HIV disease/Symptom distress and self-care burden among wom 22462
ve/Reducing emotional in individuals who are HIV-positiv 42374
en/Predictors of mental and poor physical health among h 60583
y care services in Kolar District, Karnataka, India/HIV/AIDS com 12433

o community of Masaka from 1993 to date/HIV/AIDS coun
epidemic in the Federal -Brazil/The role of the University o
programme in Masaka, Uganda: Practicalities, problems
DS prevention in Mpigi (Uganda)/Constraints to condom
ommunity in Masaka /The impact and response of traini
on analysis in Uganda/ expanded response initiative (DRI
alysis in Burkina Faso/ response initiative (DRI): Fosterin
e refugees in Adjumani,northern Uganda/AIDS preventio
AIDS in the Manikganj of Bangladesh/Adolescents and A
munities of the Lilongwe in Malawi/Contributing factors to h
alcoholics in Machakos /Communicating dangers of HIV in
ood handlers in Kajiado, Kenya/HIV, syphilis and HTLV pr
nsion project in the First of Zambales/STD, HIV/AIDS awar
evalence in rural Rakai,Uganda: Results from a populatio
V/AIDS transmission in district health structures: Impact of preven
uth in school in Kajiado, Kenya/Knowledge, attitudes and
om the field in a remote of northern Uganda/Free condom
st demarcated red light in the in the world/The qualitative a
th HIV in a remote rural of northern Uganda/My experienc
ania/Development of a peer health educator programme i
n Adjumani and Moyo Districts, northern Uganda/Why do peopl
h care setting in redlight districts /STD/AIDS prevention in primary
ent and action by health /Getting things done on AIDS: To
tients with neurological disturbances during advanced HIV-1 infe
oreceptor utilization by divergent human immunodeficiency virus
of HIV co-infection with HIV strains/Biology and molecu
93-1997/Increasingly HIV-1 seroprevalence in male a
alth risks for a culturally diverse group of South African lesbians/M
high risk populations in locations: Puerto Ricans in New Y
ection of HIV-1 RNA of origins, including type O strains/Hi
ucation to an ethnically population in a large urban setting
elated research among patient populations/HIV-Related r
roups-working with a gay and lesbian community in Cap
r clonal HIV-1 infection/ Diversification of nef and vpu in six hemo
Os/HIV-1 intrasubtype diversification originates from the momen
c/Comprehensive and diversified HIV prevention in the Czech R
ent stages of infection/ Diversity of HIV-1 long terminal repeat seq
p immunoreactivity and diversity among HIV-1 isolates from the P
ir infants/V3 sequence of HIV-1 subtype E in infected mo
ative analysis of genetic among seropositive populations i
/Analysis of the genetic of HIV-1 group O/Analysis of the
V-1 subtyping/Genetic of HIV-1 in Tanzania: Use of hete
ers in Thailand/Genetic of HIV-1 subtype E from recent s
in Europe: Geographic and time trends/The HIV/AIDS e
985-1996)/Increasing of HIV-1 serotypes in French blo
monitoring HIV genetic in the United States/Prevalence
d linguistic and cultural /Obtaining "informed consent" fo
m, subtype, nucleotide and drug resistance of HIV-1 in s

13419
13484
13543
33110
33262
34110
34127
43339
43353
60098
60155
60210
60539
60932
13490
13546
466*/14263
14288
24301
33522
33120
43348
43536
32222
11115
11162
23560
14238
14297
343*/41129
42229
42248
60832
11146
11197
60442
11148
11172
11184
11188
11195
13110
13155
13181
13204
13225
44128
60171
44167
12206
129*/12219
12357
31108
12359
22334

mination, jurisdictional divisions,testing and confidentiality/Lega
p between delavirdine ( DLV) plasma levels, HIV RNA responses a
atients with Rescriptor ( ) + Retrovir (ZDV) + Epivir (3TC)/Interi
d study of Rescriptor~ (, delavirdine mesylate) in triple and qu
rapy: DDI/delaviridine ( ), AZT/DLV, DDI/AZT or DDI/AZT/DLV
lerability for efavirenz ( DMP 266) in combination with indinavir (ID
enz (EFV, SUSTIVAT, 266) in combination with open-label z